Informations générales (source: ClinicalTrials.gov)
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY) (VOYAGER)
Observational
Hoffmann-La Roche (Voir sur ClinicalTrials)
novembre 2022
décembre 2027
17 décembre 2024
The VOYAGER study is a primary data collection, non-interventional, prospective,
multinational, multicenter study. It is designed to collect real-world, long-term data to
explore long-term effectiveness, safety, clinical insights, treatment patterns, and
factors driving the treatment decisions among patients being treated with specified Roche
ophthalmology products in approved retinal indications (Faricimab for neovascular
age-related macular degeneration [nAMD], diabetic macular edema [DME], and retinal vein
occlusion; Port Delivery System with Ranibizumab for nAMD) in routine clinical practice.
This study will not provide or make recommendations on use of any products including
Roche products; treatment decisions will be determined by the treating physician and must
be made independently to the decision to participate in this study. Participation in this
study will not change or influence a patient's standard of care in any way.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CH DE VERSAILLES SITE ANDRE MIGNOT | Contact (sur clinicalTrials) | ||||
| CHI DE CRETEIL | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Aix Vision - 13090 - Aix En Provence - France | Contact (sur clinicalTrials) | ||||
| Alpes Retine - 38330 - Montbonnot-Saint-Martin - France | Contact (sur clinicalTrials) | ||||
| Centre Des Arceaux - 34000 - Montpellier - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier de la Croix Rousse - 69317 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Centre Ophtalmologique d?Imagerie et de Laser - 75015 - Paris - France | Contact (sur clinicalTrials) | ||||
| Centre Ophtalmologique de L'Odeon - 75006 - Paris - France | Contact (sur clinicalTrials) | ||||
| Centre Ophtalmologique Kleber - 69006 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Centre Ophtalmologique Rabelais - 69002 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Centre Optha Du Dauphine - 38000 - Grenoble - France | Contact (sur clinicalTrials) | ||||
| Centre Rétine Gallien - 33000 - Bordeaux - France | Contact (sur clinicalTrials) | ||||
| Centre St Exupery - 37540 - St Cyr Sur Loire - France | Contact (sur clinicalTrials) | ||||
| CH St Joseph - 13285 - Marseille - France | Contact (sur clinicalTrials) | ||||
| CHU de Nantes - Hotel Dieu - 44093 - Nantes - France | Contact (sur clinicalTrials) | ||||
| CHU de St-Etienne - Hopital Nord - 42055 - Saint Etienne - France | Contact (sur clinicalTrials) | ||||
| CHU Dijon - Hopital Francois Mitterrand - Dijon Cedex - France | Contact (sur clinicalTrials) | ||||
| CHU Nice - Hôpital Saint Roch - 06006 - Nice - France | Contact (sur clinicalTrials) | ||||
| CHU Poitiers - Hôpital la Milétrie; Centre d'Investigation Clinique - 86021 - Poities Cedex - France | Contact (sur clinicalTrials) | ||||
| Clinique de l'Union - 31240 - Saint-jean - France | Contact (sur clinicalTrials) | ||||
| Clinique de Montargis - 45200 - Montargis - France | Contact (sur clinicalTrials) | ||||
| Clinique des Yeux Bordeaux - 33270 - Bordeaux Floirac - France | Contact (sur clinicalTrials) | ||||
| Clinique du Val d'Ouest- Institut Rhône Alpin - 69130 - Ecully - France | Contact (sur clinicalTrials) | ||||
| Clinique Honore Cave - 82000 - Montauban - France | Contact (sur clinicalTrials) | ||||
| Clinique Sourdille - 44046 - Nantes cedex 1 - France | Contact (sur clinicalTrials) | ||||
| Groupe Hospitalier Pellegrin - 33000 - Bordeaux - France | Contact (sur clinicalTrials) | ||||
| Hopital d'Instruction des Armées Desgenettes - 69003 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Hôpital Nord - CHU Marseille# - 13915 - Marseille - France | Contact (sur clinicalTrials) | ||||
| Hopital Purpan - 31000 - Toulouse - France | Contact (sur clinicalTrials) | ||||
| Hopital Saint Vincent de Paul - GHICL Lille - Parent - 59020 - Lille - France | Contact (sur clinicalTrials) | ||||
| Hôpital Saint-Louis - La Rochelle - 17019 - La Rochelle cedex - France | Contact (sur clinicalTrials) | ||||
| Institut Sourdille - 44800 - St Herblain - France | Contact (sur clinicalTrials) | ||||
| OPH95 - 95520 - Osny - France | Contact (sur clinicalTrials) | ||||
| Visiopole Private Practice - 17140 - Lagord - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
1. Have provided informed consent, as required per local regulations 2.a) Adult
patient, as defined by local regulations and local product label, who is newly
initiating treatment (or initiated treatment in the previous visit) with a specified
approved Roche ophthalmology product in retinal indication of interest for this
study in at least one eye, according to the investigator's discretion in routine
clinical practice; OR 2.b) Adult patient, as defined by local regulations and local
product label, who is continuing treatment with any specified approved Roche
ophthalmology product in retinal indication of interest for this study in at least
one eye after initiating that treatment in a Roche interventional trial.
1. Have provided informed consent, as required per local regulations 2.a) Adult
patient, as defined by local regulations and local product label, who is newly
initiating treatment (or initiated treatment in the previous visit) with a specified
approved Roche ophthalmology product in retinal indication of interest for this
study in at least one eye, according to the investigator's discretion in routine
clinical practice; OR 2.b) Adult patient, as defined by local regulations and local
product label, who is continuing treatment with any specified approved Roche
ophthalmology product in retinal indication of interest for this study in at least
one eye after initiating that treatment in a Roche interventional trial.
1. Concomitant participation of the patient in an investigational ophthalmology
clinical trial that includes receipt of any investigational drug or procedure within
the last 28 days prior to enrollment (this restriction does not apply to patients
who are rolling over from Roche interventional studies and continuing treatment with
any specified approved Roche ophthalmology product in retinal indication of interest
for this study)